The Master Plan for Ecuador's Military & Public Healthcare Evolution
PADIS consolidates HE-1 (Quito) and HOSNAG (Guayaquil) capacities into a monumental 3rd and 4th level macro-complex at the ESPE Campus. A 25-year operational concession integrating world-class care, R&D, and biological medicine manufacturing.
The Operator Consortium Model
The project execution requires a highly specialized, three-pillar corporate structure to guarantee funding, rapid construction, and flawless 25-year administration.
Israeli Planning & Lead Operators
Providing executive control, medical technology transfer, R&D protocols, and securing international financing for the CAPEX.
Ecuadorian Construction Firms
Class-A national contractors executing the massive physical build at the ESPE Campus, ensuring compliance with SERCOP and local regulations.
Local Management & Admin
Ecuadorian administrative experts handling day-to-day HR, local logistics, and managing billing/derivations with ISSFA and RPIS.
Guaranteed Patient Demand (Operational Engine)
Active Military Personnel
Priority 3rd level care for Army, Navy, and Air Force operational readiness.
ISSFA Beneficiaries
Retirees and dependents. Fully funded through Social Security (ISSFA) military contributions.
General Public (RPIS Derivations)
Ministry of Public Health derivations. Selling highly specialized services (Oncology, Hemodialysis) to the public network generates the primary profit margins.
Steady Income Mechanism
The operator does not rely on out-of-pocket payments from patients. Income is secured institutionally. Emergencies (Manchester I/II) are admitted 24/7. Scheduled complex procedures require an ISSFA/RPIS validation code, legally obligating the State to pay the Operator Consortium for services rendered.
Clinical Scope & Capacities
Detailed infrastructure capacities and the 30+ specialized medical departments.
Care Spaces & Capacities
Complete Medical & Operational Specialties
Integrating the historic portfolios of HE-1 and HOSNAG, elevated to Level 3 & 4 complexity.
Clinical Specialties
- Acupuncture
- Allergology
- Cardiology
- Dermatology
- Endocrinology
- Gastroenterology
- Genetics
- Geriatrics
- Hematology
- Infectology
- Internal Medicine
- Nephrology
- Pneumology
- Neurology
- Nutrition
- Oncology
- Psychology
- Psychiatry
- Rheumatology
Surgical Specialties
- General Surgery
- Cardiothoracic Surgery
- Plastic Surgery
- Vascular Surgery
- Neurosurgery
- Traumatology
- Urology
- Otorhinolaryngology
- Ophthalmology
Odontology & Maxillofacial
- Oral Rehabilitation
- Operative & Aesthetic Dentistry
- Oral Implantology
- Dental Imaging & Lab
Maternal, Pediatric & Critical
- Gynecology
- Pediatrics
- Neuropediatrics
- Physiatry
- Physical Med & Rehab
- Pain Therapy
- Palliative Care
Diagnostics & Support
- Radiology & Imaging
- Clinical Laboratory
- Microbiology
- Immunology
- Anatomic Pathology
- Institutional Pharmacy
- Blood Bank
- Radiotherapy
- Transplant Lab
Technical & Construction Master Plan
Based on the Conceptual Cluster Model, translating medical needs into rigorous engineering, biosafety, and architectural execution.
Master Zoning & Conceptual Cluster Plan
10-Story structural tower with base seismic isolation. Houses 165 census beds, 27 ICU beds, and surgical suites equipped with positive pressure HVAC.
Horizontal extension managing daily flow. Contains 111 consulting rooms, heavy imaging equipment (TAC simulators), and radiotherapy bunkers.
Isolated negative-pressure wing. Designed for Level 4 animal testing and nanotechnology research in direct coordination with ESPE academia.
ISO-classified cleanroom environment built to strict Good Manufacturing Practice standards for synthesizing biological and autoimmune medicines.
Architectural & Structural Engineering
Designed as a "Teaching Hospital" integrated into the ESPE campus, requiring high-end physical resilience and smart space management.
- Seismic Base Isolation: Advanced structural engineering ensuring operational continuity during severe seismic events (crucial for the Sangolquí/Quito geography).
- The Cluster Layout: Methodological design separating ambulatory traffic, critical care, and the R&D wing to optimize flow and prevent cross-contamination.
- 10-Story Main Tower: Vertical integration of the 165 hospitalization beds with rapid-access elevator cores connecting directly to the surgical suites.
Biosafety & Environmental Control
Integrating Level 4 capabilities requires flawless environmental engineering, specifically for the biological medicines and animal testing facilities.
- ISO Classified Cleanrooms: Particle-controlled environments adhering to Good Manufacturing Practice (GMP) for the Biological Medicines Factory.
- Advanced HVAC Systems: Independent positive pressure (for ORs and immunodeficient patients) and negative pressure (for infectology and the Bioterium) ventilation.
- Bio-waste Management: Integrated decontamination autoclaves and ecological disposal systems ensuring zero environmental hazard to the ESPE campus.
Technology & Infrastructure Systems
The physical build must support heavy medical machinery and automated logistics from day one of the 25-year concession.
- Radiotherapy Bunkers: High-density, lead-lined structural concrete rooms specifically engineered to house Linear Accelerators safely.
- Pneumatic Tube Logistics: Networked tube system allowing rapid, automated transport of laboratory samples and pharmacy items across the entire complex.
- Smart Grid & Medical Gases: Redundant electrical substations and centralized medical gas pipelines (Oxygen, Nitrous Oxide, Vacuum) embedded into the structural core.
Level 4 Integration: R&D & Pharma
The unique value proposition elevating PADIS above standard hospital models.
Centers of Excellence & Technology
Moving beyond treatment into generation of knowledge. Funded directly by the established CAPEX budget.
- Nanotechnology: Joint research with ESPE academic departments.
- Health Tech Assessment: Evaluating and validating advanced medical devices for the Ecuadorian market.
- Specialized Focus: Heart disease, nephrology, autoimmune disorders, and breast cancer.
The Bioterium (Preclinical Research)
A classified, bio-secure ISO environment for in-vivo preclinical testing, an absolute necessity for 4th level medical development.
- Breeding and maintenance of animal models.
- Strict adherence to international bioethical standards.
- Forms the crucial testing bridge before human trials in the biological medicines factory.
Biological Medicines Factory
The highest-margin revenue generator of the project. Transforming lab research into commercial and practical treatments.
- Production Lines: Specialized in high-cost therapies for Breast Cancer and severe Autoimmune conditions.
- Market Output: Supplying PADIS internal needs, direct sales to the Ministry of Public Health (RPIS), and Andean exports.
- Tech Transfer: Leveraging Israeli consortium IP to localize high-value biologicals.
Estimated Costs
Initial Capital Expenditure (CAPEX) for the PADIS project realization.
Total Estimated Capital Investment
This budget encompasses the complete structural construction at the ESPE Campus, procurement of all advanced medical and laboratory equipment, and comprehensive technology transfer. All capital investments occur exclusively during the building and equipping stage prior to the operational handover.